GenePOC

GenePOC is a Canadian company dedicated to developing and commercializing rapid molecular diagnostic devices for infectious diseases. Founded in 2007 by Dr. Michel Bergeron, it has been a subsidiary of Debiopharm Group since 2016. The company aims to enhance patient care through fast, high-quality diagnostic solutions that support targeted therapeutic decisions. The flagship product, the revogene® system, is a compact, automated diagnostic instrument that utilizes patented single-use cartridges and real-time PCR techniques. This system allows for rapid detection of infectious agents in about one hour, significantly improving diagnosis speed compared to traditional methods. GenePOC offers a range of rapid molecular assays for various infectious diseases, including Group A and B Streptococcus, Clostridium difficile, and carbapenemase-producing bacteria, with plans for additional assays targeting sexually transmitted diseases. GenePOC's solutions are designed for healthcare professionals and institutions that require point-of-care testing. The company is committed to addressing antimicrobial resistance and has received recognition for its innovative designs, including the Frost & Sullivan Disruptive Innovator Award and the Red Dot Design “Best of the Best” award.

• Employees 8
• Founded 2007
• Annual Revenue $1000000